Heat Biologics (HTBX) Posts Q3 Loss of 46c/Share

Heat Biologics (NASDAQ: HTBX) reported Q3 EPS of ($0.46), $0.04 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Heat Biologics (HTBX) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c